Summary
The majority (about 90%) of children developing Type 1 (insulin-dependent) diabetes mellitus do not have a first-degree relative with the disease. Nearly all (389/405, 96%) children (0–14 years) in Sweden, who developed diabetes during one year, were therefore studied to compare islet cell, thyroid peroxidase, thyroglobulin, and gastric H+, K+-ATPase antibodies with 321 age, sex, and geographically matched, but non-related, control children. Islet cell (cytoplasmic) antibodies were found in 81% (316/389) of the patients and in 3% (9/321) of the control children (p<0.001). The median islet cell antibody levels were 70 (range 3–8200) Juvenile Diabetes Foundation (JDF) Units in the islet cell antibody positive patients, and 27 (range 17–1200) JDF Units in the control children (NS). Autoantibodies against thyroid peroxidase (8%), thyroglobulin (6%), and gastric H+, K+- ATPase (3%) were all increased in the patients compared with the control children, being 2% (p<0.001), 2% (p<0.01), and 0.3% (p<0.01), respectively. During an observation time of 20–34 months, two of the nine islet cell antibody positive control children developed Type 1 diabetes, after 8 and 25 months respectively, while the others remained healthy and became islet cell antibody negative. None of the islet cell antibody negative control children developed diabetes during the same time of observation. This first investigation of an unselected population of diabetic children and matched control children shows: that islet cell antibodies are strongly associated with newly diagnosed childhood diabetes, that other autoantibodies are more frequent among diabetic children than control children, and that the frequency of islet cell antibodies in the background population of children is higher than previously documented, and could also be transient, underlining that factors additional to islet cell antibodies are necessary for the later development of Type 1 diabetes.
Article PDF
Similar content being viewed by others
References
Diabetes Mellitus (1985) Report of a WHO Study Group, World Health Organization Technical Report Series. World Health Organization, Geneva No. 727: 7–13
Cahill GF, McDevitt HO (1981) Insulin-dependent diabetes mellitus: the initial lesion. N Engl J Med 304: 1454–1465
Hamman RF, Berlin N (1985) International workshop on the epidemiology of insulin-dependent diabetes mellitus. Diabetes Care 8 [Suppl 1]: 1–109
Borch-Johnsen K, Kreiner S, Deckert T (1986) Mortality of Type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish Type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 29: 767–772
Dorman JS, Tajima N, LaPorte RE, Becker DJ, Cruickshanks KJ, Wagener DK, Orchard TJ, Drash AL (1985) The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study: case-control analyses of risk factors for mortality study: case-control analyses of risk factors for mortality. Diabetes Care 8 [Suppl 1]: 54–60
Dahlquist G, Blom L, Holmgren G, Hägglöf B, Larsson Y, Sterky G, Wall S (1985) The epidemiology of diabetes in Swedish children 0–14 years — A sex-year prospective study. Diabetologia 28: 802–808
Åkerblom HK, Reunanen A (1985) The epidemiology of insulin-dependent diabetes mellitus (IDDM), in Finland and in Northern Europe. Diabetes Care 8 [Suppl 1]: 10–16
Patterson CC, Thorogood M, Smith PG, Heasman MA, Clarke JA, Mann JI (1983) Epidemiology of type 1 (insulin-dependent) diabetes in Scotland 1968–1976; evidence of an increasing incidence. Diabetologia 24: 238–243
Palumbo P, LaBarthe D (1978) The incidence of diabetes mellitus in Rochester, Minnesota, 1945–1969. Adv Metab Disord 9: 13–28
Adams SF (1926) The seasonal variation in the onset of acute diabetes. Arch Intern Med 37: 861–864
Gamble DR, Taylor KW (1969) Seasonal incidence of diabetes mellitus. Br Med J 3: 631–633
Tattersall RB, Pyke DA (1972) Diabetes in identical twins. Lancet II: 1120–1125
Barnett AH, Eff C, Leslie RDG, Pyke DA (1981) Diabetes in identical twins. Diabetologia 20: 87–93
Gamble DR (1977) Viruses and diabetes: an overview with special reference to epidemiological studies. In: Bajaj JS (ed) Proceedings of the IX congress of the International Diabetes Federation. Excerpta Medica, Amsterdam, Oxford pp 285–293
Yoon JW, Austin M, Onodera T, Notkins AL (1979) Virus-induced diabetes mellitus. N Engl J Med 300: 1173–1179
Ginsberg-Fellner F, Witt ME, Yagihashi S, Dobersen MJ, Taub F, Fedun B, McEvoy RC, Roman SH, Davies TF, Cooper LZ, Rubinstein P, Notkins AL (1984) Congenital rubella syndrome as a model for Type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 27: 87–89
Rayfield EJ, Seto Y (1978) Viruses and the pathogenesis of diabetes mellitus. Diabetes 27: 1126–1140
Helgason T, Jonasson MR (1981) Evidence for a food additive as a cause of ketosis-prone diabetes. Lancet II: 716–720
Karam JH, Lewitt PA, Young CW, Nowlain RE, Frankel BJ, Fujiya H, Freedman ZR, Grodsky GM (1980) Insulinopenic diabetes after rodenticide (Vacor) ingestion. A unique model of acquired diabetes in man. Diabetes 29: 971–978
Powers AC, Eisenbarth GS (1985) Autoimmunity to islet cells in diabetes mellitus. Ann Rev Med 36: 533–544
Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–143
Lernmark Å, Li S, Baekkeskov S, Christie M, Michelsen B, Ursing J, Landin-Olsson M, Sundkvist G (1987) Islet-specific immune mechanisms. Diabetes Metab Rev 3: 959–980
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Foulis AK, Stewart JA (1984) The pancreas in recent-onset Type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26: 456–461
Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360
Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24: 366–371
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet II: 1279–1283
MacCuish AC, Barnes EW, Irvine WJ, Duncan LJP (1974) Antibodies to pancreatic islet-cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet II: 1529–1531
Lernmark Å, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS (1978) Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med 299: 375–380
Dobersen MJ, Scharff JE, Ginsberg-Fellner F, Notkins AL (1980) Cytotoxic autoantibodies to beta-cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 303: 1493–1498
Eisenbarth GS, Morris MA, Scearce RM (1981) Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J Clin Invest 67: 403–408
Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167–169
Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, de Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, Sundkvist G, Lernmark Å (1987) Antibodies to a Mr 64,000 human islet cell antigen precede the clinical onset of insulin dependent diabetes. J Clin Invest 79: 926–934
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG (1981) Evidence for a long prediabetic period in Type 1 (insulin-dependent) diabetes mellitus. Lancet II: 1363–1365
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with Type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313: 462–464
MacCuish AC, Irvine WJ (1975) Autoimmunological aspects of diabetes mellitus. Clin Endocrinol Metab 4: 435–471
Bottazzo GF, Cudworth AG, Moul DJ, Doniach D, Festenstein H (1978) Evidence for a primary autoimmune type of diabetes mellitus. Br Med J 2: 1253–1255
Lendrum R, Walker G, Gamble DR (1975) Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet I: 880–883
Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhar JW, Vaughan H, Morris PJ (1977) Pancreatic islet cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA-type. Diabetes 26: 138–147
Del Prete GF, Betterle C, Padovan D, Erle G, Toffolo A, Borsahi G (1977) Incidence and significance of islet-cell auto-antibodies in different types of diabetes mellitus. Diabetes 26: 909–915
Lernmark Å, Hägglöf B, Freedman Z, Irvine J, Ludvigsson J, Holmgren G (1981) A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children. Diabetologia 20: 471–474
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D (1980) Complement-fixing islet-cell antibodies in type 1 diabetes: possible monitors of active beta-cell damage. Lancet I: 668–672
Helmke K, Otten A, Mäser E, Wolf H, Federlin K (1987) Islet cell antibodies, circulating immune complexes and antinuclear antibodies in diabetes mellitus. Horm Metab Res 19: 312–315
Kolb H, Dannehl K, Grüneklee D, Zielasek J, Bertrams J, Hübinger A, Gries FA (1988) Prospective analysis of islet cell antibodies in children with Type 1 (insulin-dependent) diabetes. Diabetologia 31: 189–194
Maclaren NK, Horne G, Spillar RP, Barbour H, Harrison D, Duncan J (1985) Islet cell antibodies (ICA) in U.S. school children. Diabetes 34 [Suppl 1]: 84 (Abstract)
Bergua M, Solé J, Marion G, Perez MC, Recasens A, Fernandez J, Casamitjana R, Gomis R (1987) Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren. Diabetologia 30: 724–726
Braining GJ, Molenaar JL, Grobbee DE, Hofman A (1988) A 10 year retrospective follow-up of islet cell antibody positivity in children of a township in Holland. Diabetologia 31: 474 (Abstract)
Karjalainen J (1988) Prevalence of cytoplasmic islet cell antibodies in a Finnish 3–18 year-old general population — a crosssectional study of 1206 subjects. Diab Res Clin Pract 5 [Suppl 1]: 254 (Abstract)
Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandström A, Wall S (1989) The Swedish childhood diabetes study — Results from a nine year case register and one year case-referent study indicating that Type 1 (insulin-dependent) diabetes mellitus is associated with both Type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32: 2–6
Heding LG (1975) Radioimmunological determination of C-peptide in serum. Diabetologia 11: 541–548
Madsen OD, Landin-Olsson M, Bille G, Sundkvist G, Lernmark Å, Dahlqvist G, Ludvigsson J (1986) A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies. Diabetologia 29: 115–118
Landin-Olsson M, Sundkvist G, Lernmark Å (1987) Prolonged incubation on the two-colour immunofluorescent test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 327–332
Madsen OD, Cohen RM, Fitch FW, Rubenstein AH, Steiner DF (1983) The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure. Endocrinol 113: 2135–2144
Pilcher C, Elliot RB (1984) Improved sensitivity of islet cell cytoplasmic antibody assays in diabetics. Lancet 1: 1352
Bonifacio E, Lernmark Å, Dawkins RL (1988) Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 106: 83–88
Gustavsson J, Mendel-Hartvig I, Tötterman TH, Karlsson FA (1987) Purification of human thyroid peroxidase using ion exchange liquid chromatography. J Clin Lab Immunol 23: 57–61
Karlsson FA, Burman P, Lööf L, Mårdh S (1988) Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+, K+-adenosin triphosphatase of the stomach. J Clin Invest 81: 475–479
Karlsson FA, Burman P, Lööf L, Olsson M, Scheynius A, Mårdh S (1987) Enzyme linked immunosorbent assay of H+, K+-ATPase, the parietal cell antigen. Clin Exp Immunol 70: 604–610
Bottazzo GF, Gleichman H (1986) Workshop report. Immunology and diabetes workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 29: 125–126
Christie M, Landin-Olsson M, Sundkvist G, Dahlquist G, Lernmark Å, Bækkeskov S (1988) Antibodies to a Mr64,000 islet cell protein in Swedish children with newly diagnosed Type 1 (insulin-dependent) diabetes. Diabetologia 31: 597–602
Rotter JI, Rimoin DL (1978) Heterogeneity in diabetes mellitusupdate. Diabetes 27: 599–608
Rotter JI, Rimoin DL (1981) The genetics of the glucose intolerance disorders. Am J Med 70: 116–126
Wolf E, Spencer KM, Cudworth AG (1983) The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA- DR association. Diabetologia 24: 224–230
Platz P, Jakobsen BK, Morling M, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M (1981) HLA-D and DR-antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115
Owerbach D, Lernmark Å, Platz P, Ryder LP, Rask L, Peterson PA, Ludvigsson J (1983) HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303: 815–817
Nepom BS, Palmer J, Kim SJ, Hansen JA, Holbeck SL, Nepom GT (1986) Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med 164: 345–350
Michelsen B, Lernmark Å (1987) Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 79: 1144–1152
Helmke K, Otten A, Willems WR, Brockhaus R, Mueller-Eckhardt G, Stief T, Bertrams J, Wolf H, Federlin K (1986) Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 29: 30–33
Millward BA, Alviggi L, Hoskins PJ, Johnston C, Heaton D, Bottazzo GF, Vergani D, Leslie RD, Pyke DA (1986) Immune changes associated with insulin-dependent diabetes may remit without causing the disease, a study in identical twins. Br Med J 292: 793–796
Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K (1987) Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of Type 1 diabetes. Diabetes 36: 510–517
Tarn AC, Thomas JN, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EAM (1988) Predicting insulin-dependent diabetes. Lancet I: 845–850
Vialkow PJ, Zavala C, Nielsen R (1975) Thyroid autoimmunity: Increased frequency in relatives of insulin-dependent diabetes patients. Ann Int Med 83: 170–176
Maclaren NK, Riley WJ (1985) Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care 8 [Suppl 1]: 34–38
Nordén G, Jensen E, Stilbo I, Bottazzo GF, Lernmark Å (1983) B-cell function and islet cell and other organ-specific autoantibodies in relatives to insulin-dependent diabetic patients. Acta Med Scand 213: 199–203
Ivarsson SA, Johansson E, Nilsson KO, Thorell JI (1987) Urinary C-peptide excretion at onset of insulin-dependent diabetes mellitus in children. Acta Paediatr Scand 76: 608–611
Author information
Authors and Affiliations
Additional information
The names of the co-workers are listed in the Acknowledgement section
Rights and permissions
About this article
Cite this article
Landin-Olsson, M., Karlsson, A., Dahlquist, G. et al. Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32, 387–395 (1989). https://doi.org/10.1007/BF00277264
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00277264